253 related articles for article (PubMed ID: 22001899)
1. Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1).
Zheng Y; Guo C; Zhang Y; Qi H; Sun Q; Xu E; Zhang Y; Ma D; Wang Y
Int Immunopharmacol; 2011 Dec; 11(12):2188-93. PubMed ID: 22001899
[TBL] [Abstract][Full Text] [Related]
2. Allergic rhinitis induced by intranasal sensitization and challenge with trimellitic anhydride but not with dinitrochlorobenzene or oxazolone in A/J mice.
Farraj AK; Harkema JR; Kaminski NE
Toxicol Sci; 2004 Jun; 79(2):315-25. PubMed ID: 15056815
[TBL] [Abstract][Full Text] [Related]
3. An antagonist for CCR4 alleviates murine allergic rhinitis by intranasal administration.
Qi H; Zheng Y; Xu E; Guo C; Zhang Y; Sun Q; Xiao J; Ma D; Wang Y
Int Arch Allergy Immunol; 2012; 159(3):297-305. PubMed ID: 22739408
[TBL] [Abstract][Full Text] [Related]
4. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.
Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N
Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
Won TB; Quan SH; Kim DY; Rhee CS; Lee CH
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603
[TBL] [Abstract][Full Text] [Related]
6. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis.
Han DM; Zhou B; Wang T; Wang XD; Fan EZ
Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982
[TBL] [Abstract][Full Text] [Related]
7. Topical levamisole hydrochloride therapy attenuates experimental murine allergic rhinitis.
Wang H; Zhang J; Gao C; Zhu Y; Wang C; Zheng W
Eur J Pharmacol; 2007 Dec; 577(1-3):162-9. PubMed ID: 17935711
[TBL] [Abstract][Full Text] [Related]
8. The CKLF1-C19 peptide attenuates allergic lung inflammation by inhibiting CCR3- and CCR4-mediated chemotaxis in a mouse model of asthma.
Tian L; Li W; Wang J; Zhang Y; Zheng Y; Qi H; Guo X; Zhang Y; Ma D; Shen H; Wang Y
Allergy; 2011 Feb; 66(2):287-97. PubMed ID: 21208220
[TBL] [Abstract][Full Text] [Related]
9. Effect of 5-aminosalicylate on allergic rhinitis model in mice.
Kuyama S; Yamamoto A; Sugiyama M; Kakuta H; Sugimoto Y
Int Immunopharmacol; 2010 Jun; 10(6):713-6. PubMed ID: 20304104
[TBL] [Abstract][Full Text] [Related]
10. Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis.
Kim YH; Yang TY; Park CS; Ahn SH; Son BK; Kim JH; Lim DH; Jang TY
Allergy; 2012 Feb; 67(2):183-90. PubMed ID: 22050307
[TBL] [Abstract][Full Text] [Related]
11. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells.
Aoi N; Masuda T; Murakami D; Yajima T; Mizubuchi H; Yamada H; Kawauchi H; Yoshikai Y
J Allergy Clin Immunol; 2006 Jun; 117(6):1359-66. PubMed ID: 16750998
[TBL] [Abstract][Full Text] [Related]
12. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis.
KuoLee R; Zhou H; Harris G; Zhao X; Qiu H; Patel GB; Chen W
Clin Exp Allergy; 2008 Jun; 38(6):1003-15. PubMed ID: 18307525
[TBL] [Abstract][Full Text] [Related]
14. In vivo intranasal anti-CD23 treatment inhibits allergic responses in a murine model of allergic rhinitis.
Zhou M; Du D; Zhao K; Zheng C
J Mol Histol; 2013 Jun; 44(3):327-38. PubMed ID: 23377922
[TBL] [Abstract][Full Text] [Related]
15. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.
Benson M; Strannegård IL; Strannegård O; Wennergren G
J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075
[TBL] [Abstract][Full Text] [Related]
16. The role of hypoxia-inducible factor 1α in allergic rhinitis.
Mo JH; Kim JH; Lim DJ; Kim EH
Am J Rhinol Allergy; 2014; 28(2):e100-6. PubMed ID: 24717944
[TBL] [Abstract][Full Text] [Related]
17. [Influence of aluminum hydroxide adjuvant on a murine model of allergic rhinitis].
Lin L; Yan W; Zhao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun; 28(11):780-4. PubMed ID: 25219201
[TBL] [Abstract][Full Text] [Related]
18. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis.
Meltzer EO
Ann Allergy Asthma Immunol; 1998 Aug; 81(2):128-34. PubMed ID: 9723557
[TBL] [Abstract][Full Text] [Related]
19. Role of Interleukin-17A on the Chemotactic Responses to CCL7 in a Murine Allergic Rhinitis Model.
Zhang YL; Han DH; Kim DY; Lee CH; Rhee CS
PLoS One; 2017; 12(1):e0169353. PubMed ID: 28046055
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation.
Stebbins KJ; Broadhead AR; Correa LD; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
Eur J Pharmacol; 2010 Jul; 638(1-3):142-9. PubMed ID: 20447387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
